586
Views
0
CrossRef citations to date
0
Altmetric
Articles

Bicistronic vector-based procedure to measure correlative expression and bacteriostatic activity of recombinant neutrophil gelatinase-associated lipocalin

, , , , , & show all
Pages 545-552 | Received 04 Feb 2022, Accepted 12 Jul 2022, Published online: 08 Sep 2022

References

  • Kjeldsen L. Gelatinase granules in human neutrophils. Eur J Haematol Suppl. 1995;56:1–30.
  • Schenkels LC, Veerman EC, Nieuw Amerongen AV. EP-GP and the lipocalin VEGh, two different human salivary 20-kDa proteins. J Dent Res. 1995;74(9):1543–1550.
  • Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276(40):37258–37265.
  • Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10(5):1033–1043.
  • Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14(10):2534–2543.
  • Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–1238.
  • Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36(3):452–461.
  • Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22(12):2089–2095.
  • McWilliam SJ, Antoine DJ, Jorgensen AL, et al. Urinary biomarkers of aminoglycoside-induced nephrotoxicity in cystic fibrosis: kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin. Sci Rep. 2018;8(1):5094.
  • Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52(3):595–605.
  • Schmidt-Ott KM, Mori K, Li JY, et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2007;18(2):407–413.
  • Su WW. Fluorescent proteins as tools to aid protein production. Microb Cell Fact. 2005;4(1):12.
  • Arai R, Ueda H, Kitayama A, et al. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001;14(8):529–532.
  • Martinez-Salas E. Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol. 1999;10:458–464.
  • Bayat H, Hoseinzadeh S, Pourmaleki E, et al. Evaluation of different vector design strategies for the expression of recombinant monoclonal antibody in CHO cells. Prep Biochem Biotechnol. 2018;48(2):160–164.
  • Liu S, Bugos RC, Dharmasiri N, et al. Green fluorescent protein as a secretory reporter and a tool for process optimization in transgenic plant cell cultures. J Biotechnol. 2001;87(1):1–16.
  • March JC, Rao G, Bentley WE. Biotechnological applications of green fluorescent protein. Appl Microbiol Biotechnol. 2003;62(4):303–315.
  • Cha HJ, Dalal NG, Pham MQ, et al. Insect larval expression process is optimized by generating fusions with green fluorescent protein. Biotechnol Bioeng. 1999;65(3):316–324.
  • Zhou Y, Aran J, Gottesman MM, et al. Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector. Hum Gene Ther. 1998;9(3):287–293.
  • Mizuguchi H, Xu Z, Ishii-Watabe A, et al. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000;1(4):376–382.
  • Yu X, Zhan X, D’Costa J, et al. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther. 2003;7(6):827–838.
  • Miethke M, Skerra A. Neutrophil gelatinase-associated lipocalin expresses antimicrobial activity by interfering with L-norepinephrine-mediated bacterial iron acquisition. Antimicrob Agents Chemother. 2010;54(4):1580–1589.
  • Gupta K, Shukla M, Cowland JB, et al. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum. 2007;56(10):3326–3335.
  • Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev. 2007;71(3):413–451.
  • Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917–921.
  • Hider RC, Kong X. Chemistry and biology of siderophores. Nat Prod Rep. 2010;27(5):637–657.
  • Saoin S, Boonkrai C, Pisitkun T, et al. Expression of secreted neutrophil gelatinase-associated lipocalin in 293T cell using the inducible dual-function system. Processes. 2021;9(5):855.
  • Thomas CL, Maule AJ. Limitations on the use of fused green fluorescent protein to investigate structure-function relationships for the cauliflower mosaic virus movement protein. J Gen Virol. 2000;81(Pt 7):1851–1855.
  • Shaimardanova AA, Kitaeva KV, AbdrakhmanovaChernov II, et al. Production and application of multicistronic constructs for various human disease therapies. Pharmaceutics. 2019;11(11):580.
  • Lee S, Kim JA, Kim HD, et al. Real-time temporal dynamics of bicistronic expression mediated by internal ribosome entry site and 2A cleaving sequence. Mol Cells. 2019;42(5):418–425.
  • Albano CR, Randers-Eichhorn L, Bentley WE, et al. Green fluorescent protein as a real time quantitative reporter of heterologous protein production. Biotechnol Prog. 1998;14(2):351–354.
  • Fischbach MA, Lin H, Zhou L, et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006;103(44):16502–16507.
  • Tang X-Y, Zhou J-B, Luo F-Q, et al. Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies. Ren Fail. 2019;41(1):446–454.
  • Pennemans V, Rigo JM, Faes C, et al. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Clin Chem Lab Med. 2013;51(9):1795–1802.